Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selenium in mild thyroid eye disease
NCT02112643Phase 3Withdrawn
- Sponsor
- Columbia University
- Start
- Oct 2015
- Primary completion
- Nov 2016
01
Overview
A Phase 3 trial of sodium selenate in thyroid eye disease (TED), sponsored by Columbia University. Planned start Oct 2015; status: withdrawn.
02
Drugs
sodium selenate
03
Conditions
thyroid eye disease (TED)
Beyond the preview
Go deeper on NCT02112643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02112643.